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Primary duodenal malignant melanoma: A case report 
 
 
Abstract 
Background: Melanoma is a neoplasm derived commonly from melanocytic cells of skin. 
Although coetaneous presentation of malignant melanoma is easily recognizable, the 
presentation of melanoma in other organs is so confusing. In particular, when it 
metastasizes to other organs, many bizarre figures and unusual organs may be involved. In 
this report, we present a case of primary duodenal malignant melanoma. 
Case Presentation: A 68-year-old man presented with a history of iron deficiency anemia. 
The upper gastrointestinal endoscopy showed a prominent papilla of duodenum along with 
an ulcerative lesion adjacent to second part of duodenum. Histopathologic evaluation 
showed a high-grade malignant neoplasm involving the bowel wall which was labeled for 
S100 protein and markers of melanocytic differentiation; Melan-A indicating the definitive 
diagnosis of malignant melanoma of the second portion of duodenal mucosa. 
Conclusions: In patients with a history of iron deficiency anemia, any GI symptom should 
be evaluated carefully. However, the diagnosis of primary GI melanomas in patients 
without any history of melanoma is possible. Full medical investigations are recommended 
in these patients with primary mucosal lesions. 
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Malignant melanoma is commonly diagnosed on skin lesions (1). This cancer is one 
of the most aggressive and life-threatening skin cancers. Malignant melanoma originate 
from the melanocytes and has a very high tendency to spread to other parts of the body. 
However, involvement of extra-cutaneous sites; such as gastrointestinal mucosa which 
may contain pigmented cells/melanocytes, are well documented in the literature (2-4). 
Unlike cutaneous melanoma, which is one of the most common malignancies with a 
significant burden on society and public health globally (5), primary mucosal melanomas 
are rare(4). Mucosal melanoma originating in duodenum with gallbladder metastasis is a 
very rare condition, which presents non-specific signs and symptoms like other 
pathological conditions of this region. Here, we present a-68-year old man who presented 
with fatigue and iron deficiency anemia. After upper gastrointestinal endoscopy and 
biopsy, pathological and immunohistochemical studies confirmed the diagnosis of 
duodenal malignant melanoma.  
 
 
Case Presentation 
A 68-year-old man was referred to our oncology clinic with the pathologic diagnosis of 
duodenal malignant melanoma. This patient had a history of controlled diabetes mellitus, 
controlled hypertension and myocardial infraction before admission. He had suffered from 
fatigue, weakness, lethargy and weight lost (more than 10%) since one month prior to 
admission. Physical examination revealed no additional clinical data.  
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A complete blood count (CBC) test showed an iron 
deficiency anemia. Thyroid function tests were normal. 
Moreover, he underwent an upper gastrointestinal endoscopy 
(GIE) and a colonoscopy that revealed some erosion around 
pylorus of stomach and a prominent papilla of duodenum 
along with an ulcerative lesion adjacent to D2. Several 
biopsies were taken from the antrum and D2 lesions. 
Histopathologic evaluation showed a high-grade 
malignant neoplasm involving the bowel wall. Tumor was 
composed of sheets of loosely cohesive pleomorphic cells 
with prominent nucleoli and eosinophilic cytoplasm. There 
was no visible melanin pigment in tumoral cells. Necrosis 
was also noted. The tumor cells labeled for S100 protein and 
markers of melanocytic differentiation; Melan-A. As 
staining for CK, LCA, CD117, and CD34 were negative, the 
diagnoses of carcinoma, lymphoma and gastrointestinal 
stromal tumor were ruled out. Morphologic and 
immunohistochemical findings were consistent with 
malignant melanoma (figures 1 and 2). 
 
 
 
 
 
 
 
 
 
 
Figure 1) IHC; a-d: CK, LCA, CD117, and CD34 were 
negative. e and f: S100 protein and Melan-A were 
positive. The tumor cells labeled for S100 protein and 
markers of melanocytic differentiation; Melan-A. As 
staining for CK, LCA, CD117, and CD34 were negative, 
the diagnosis of carcinoma, lymphoma and 
gastrointestinal stromal tumor were ruled out (red 
arrows showing the tumoral cells). 
 
Subsequently, after confirming the diagnosis of 
malignant melanoma of duodenal mucosa, the patient 
underwent secondary full medical evaluation including 
detailed inspection of the eyes, skin and mucosal surface. 
These examinations did not show any clinically significant 
lesion.  Moreover, he underwent anoscopy for any visible 
lesion that was negative. Abdominopelvic computed 
tomography (CT) scan with intravenous contrast revealed 
multiple abnormalities. CT scan exhibited an ovaloid mass in 
the gallbladder with washout in delayed phase that was 
suggestive of a tumoral lesion. There were two small nodules 
in the right adrenal and a heterogeneous hypodense mass 
(diameter: 3.2 cm) in the left adrenal. In the proximal (and to 
a lesser extent in distal) loops of the small intestine, a 
heterogeneous increase in thickness was also observed. 
Moreover, there were several mesenteric lymphadenopathies 
along the superior mesenteric artery (figure 3). 
 
 
 
 
 
 
 
 
 
 
Figure 2. Histopathologic evaluation with H&E staining; a 
high-grade malignant neoplasm involving the bowel wall. 
Tumor was composed of sheets of loosely cohesive pleomorphic 
cells with prominent nucleoli and eosinophilic cytoplasm (red 
oval shape represents region occupied by tumor cells where the 
red arrow showing the tumoral cell). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Abdominopelvic computed tomography (CT) scan with 
intravenous contrast; Abdominopelvic computed tomography (CT) 
scan with intravenous contrast revealed multiple abnormalities. CT 
scan exhibited an ovaloid mass in the gallbladder with washout in 
delayed phase that was suggestive of a tumoral lesion. There were two 
small nodules in the right adrenal and a heterogeneous hypodense mass 
(diameter: 3.2 cm) in the left adrenal. In the proximal (and to a lesser 
extent in distal) loops of the small intestine, a heterogeneous increase in 
thickness was also observed. Moreover, there were several mesenteric 
lymphadenopathies along the superior mesenteric artery (figure 3). 
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Considering the pathologic diagnosis of the duodenal 
lesion and its metastatic nature, we commenced treatment of 
patient with oral temozolomide (every 28 days) and 
scheduled further diagnostic interventions including CT 
guided fine needle aspiration biopsy of the abdominal mass 
and re-upper GIE, unfortunately he expired due to active 
disease. 
 
 
Discussion 
Malignant melanoma is a rare skin cancer causing the 
highest rate of mortality among them. There is a 
geographical variation for melanoma incidence. However, its 
incidence increased during last decades (6). In contrast to 
these facts about cutaneous types,  the prevalence of mucosal 
melanomas remains steady and they account for up to 2% of 
all melanomas mostly in esophagus and anus (7, 8). 
Melanoma originates from pigment-producing cells –
melanocytes- which are mainly located at the skin, eyes, and 
meninges. Furthermore, melanocytes exist in mucosal 
surfaces except in the small intestine mucosa (4). Cutaneous 
melanoma usually spread to lung, liver, brain and less 
gastrointestinal (GI) tract (that it mostly metastasie to small 
intestine). Gallbladder metastasis of melanoma is an 
extremely rare medical condition which was described 
mostly as case reports (9). Although, there are some reports 
of primary melanomas of these organs, the main 
pathophysiology of these primary mucosal lesions is unclear. 
Nonetheless, some investigators such as Mishimaet.Al. (10) 
and Amar et.Al. (11) suggest schwannian neuroblast cells 
and melanoblastic cells of the neural crest, the cell of origin.   
Mucosal melanoma originating in duodenum presents a 
broad spectrum of clinical features such as abdominal pain, 
intestinal obstruction, constipation, blood vomiting, melena, 
anemia, fatigue, weight loss, and presence of a palpable 
abdominal mass (12, 13). These clinical presentations mostly 
resemble ulcerative lesions of gastrointestinal tract. 
Regarding to its pathohistology, there is no expectation to 
present with GI bleeding; there are some reports about the 
first presentation of duodenal melanoma with this rare 
presentation (14).  Moreover, according to the location of GI 
tract, it can be present with complicated diagnosis such as 
painless jaundice (15). Nevertheless, other differential 
diagnosis include gastritis, esophageal varices, Meckel's 
diverticulum, and Mallory-Weiss syndrome. These various 
and different symptoms make the differentiation of 
gastrointestinal metastatic or primary mucosal melanomas 
very difficult (16). Upper GIE is the procedure of choice in 
the detection of mucosal melanomas of duodenum, as it is 
for other pathologies of upper GI tract.  Ettahri et Al. (9) 
described endoscopic findings of malignant melanoma of GI 
tract as necrotic/melanotic lesions, sub-mucosal masses, and 
ulcerated mucosal melanoma.  Like the presented patient, the 
upper GIE showed an ulcerative lesion in D2. On the other 
hand, primary malignant melanoma of the duodenum can be 
a mimicker of lymphoma or carcinoma when it is without 
visible melanin pigment (17). In patients with duodenal 
melanoma, full medical investigations include detailed 
examination of eyes, skin and mucosal surfaces, endoscopy, 
abdominopelvic CT scan with intravenous contrast, and 
positron emission tomography–computed tomography 
(PET/CT) scan are imperative. However, since cutaneous 
melanoma usually tends to regress (9), these diagnostic 
procedures may fail in detecting the primary lesion.  
moreover, these tumors may mimic other neoplasms like 
masquerading as gastrointestinal stromal tumor (18). As this 
medical condition is rare, its pathologic diagnosis needs 
immunohistochemical confirmation by HMB45, Melan-A 
and S-100 protein (4, 13). A complete immunohistochemical 
panel could result in the highest possible sensitivity and 
specificity. 
In conclusion in patients with a history of melanoma, any 
GI symptom should be evaluated carefully. Yet, the diagnosis of 
primary GI melanomas in patients without any history of 
melanoma is possible. Full medical investigations are 
recommended in these patients with primary mucosal lesions.   
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